Bicalutamide Tabi Tablet

Product Description

Bicalutamide Tabi Tablet contains the active ingredient bicalutamide, which is a nonsteroidal antiandrogen medication used primarily in the treatment of prostate cancer. These tablets are indicated for the treatment of metastatic prostate cancer in combination with a luteinizing hormone-releasing hormone (LHRH) analog or surgical castration. It works by blocking the action of androgens (male hormones) like testosterone, thereby slowing the growth and spread of prostate cancer cells. Bicalutamide Tabi Tablet competes with androgens for binding to androgen receptors in prostate cells, thereby inhibiting the growth and proliferation of prostate cancer cells.

Specification